Literature DB >> 15572211

Endogenous opiates and behavior: 2003.

Richard J Bodnar1, Gad E Klein.   

Abstract

This paper is the 26th consecutive installment of the annual review of research concerning the endogenous opioid system, now spanning over a quarter-century of research. It summarizes papers published during 2003 that studied the behavioral effects of molecular, pharmacological and genetic manipulation of opioid peptides, opioid receptors, opioid agonists and opioid antagonists. The particular topics that continue to be covered include the molecular-biochemical effects and neurochemical localization studies of endogenous opioids and their receptors related to behavior (Section 2), and the roles of these opioid peptides and receptors in pain and analgesia (Section 3); stress and social status (Section 4); tolerance and dependence (Section 5); learning and memory (Section 6); eating and drinking (Section 7); alcohol and drugs of abuse (Section 8); sexual activity and hormones, pregnancy, development and endocrinology (Section 9); mental illness and mood (Section 10); seizures and neurologic disorders (Section 11); electrical-related activity and neurophysiology (Section 12); general activity and locomotion (Section 13); gastrointestinal, renal and hepatic functions (Section 14); cardiovascular responses (Section 15); respiration and thermoregulation (Section 16); and immunological responses (Section 17).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15572211     DOI: 10.1016/j.peptides.2004.09.005

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  9 in total

1.  Differential activation of G-proteins by mu-opioid receptor agonists.

Authors:  Zuzana Saidak; Katherine Blake-Palmer; Debbie L Hay; John K Northup; Michelle Glass
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

2.  Relaxin-3/RXFP3 signalling in mouse hypothalamus: no effect of RXFP3 activation on corticosterone, despite reduced presynaptic excitatory input onto paraventricular CRH neurons in vitro.

Authors:  C Zhang; D V Baimoukhametova; C M Smith; J S Bains; Andrew L Gundlach
Journal:  Psychopharmacology (Berl)       Date:  2017-03-17       Impact factor: 4.530

Review 3.  Olfaction under metabolic influences.

Authors:  Brigitte Palouzier-Paulignan; Marie-Christine Lacroix; Pascaline Aimé; Christine Baly; Monique Caillol; Patrice Congar; A Karyn Julliard; Kristal Tucker; Debra Ann Fadool
Journal:  Chem Senses       Date:  2012-07-25       Impact factor: 3.160

Review 4.  Delta Opioids: Neuroprotective Roles in Preclinical Studies.

Authors:  Shahid Husain
Journal:  J Ocul Pharmacol Ther       Date:  2018 Jan/Feb       Impact factor: 2.671

5.  MOR1 expression in gastric cancer: a biomarker associated with poor outcome.

Authors:  Ya-sai Yao; Ru-yong Yao; Li-kun Zhuang; Wei-wei Qi; Jing Lv; Fei Zhou; Wen-sheng Qiu; Lu Yue
Journal:  Clin Transl Sci       Date:  2014-12-02       Impact factor: 4.689

6.  Mass spectrometry-based neuropeptidomics of secretory vesicles from human adrenal medullary pheochromocytoma reveals novel peptide products of prohormone processing.

Authors:  Nitin Gupta; Steven J Bark; Weiya D Lu; Laurent Taupenot; Daniel T O'Connor; Pavel Pevzner; Vivian Hook
Journal:  J Proteome Res       Date:  2010-10-01       Impact factor: 4.466

Review 7.  How may stressful experiences contribute to the development of temporomandibular disorders?

Authors:  Gustavo Hauber Gameiro; Annicele da Silva Andrade; Darcy Flávio Nouer; Maria Cecília Ferraz de Arruda Veiga
Journal:  Clin Oral Investig       Date:  2006-08-22       Impact factor: 3.573

8.  Endogenous opioids upregulate brain-derived neurotrophic factor mRNA through delta- and micro-opioid receptors independent of antidepressant-like effects.

Authors:  Huina Zhang; Mary M Torregrossa; Emily M Jutkiewicz; Yong-Gong Shi; Kenner C Rice; James H Woods; Stanley J Watson; M C Ko
Journal:  Eur J Neurosci       Date:  2006-02       Impact factor: 3.386

Review 9.  Adapted Physical Activity to Ensure the Physical and Psychological Well-Being of COVID-19 Patients.

Authors:  Grazia Maugeri; Giuseppe Musumeci
Journal:  J Funct Morphol Kinesiol       Date:  2021-01-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.